Krizman Anthony
Insider CIK 1517892 · SGNT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 8,556 | $21.75 | $186.1K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 691 | $21.75 | $15.0K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 6,379 | $10.15 | $64.7K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 760 | $21.75 | $16.5K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 1,860 | $21.75 | $40.5K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 1,381 | $21.75 | $30.0K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | U Tender | 2016-08-29 | 2016-08-31 | 7,097 | $21.75 | $154.4K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2016-02-25 | 2016-02-25 | 230 | — | $0 | 691 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2016-02-25 | 2016-02-25 | 460 | — | $0 | 1,381 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2016-02-25 | 2016-02-25 | 230 | — | $0 | 7,097 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2016-02-25 | 2016-02-25 | 460 | — | $0 | 6,867 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2016-02-22 | 2016-02-23 | 8,556 | — | $0 | 8,556 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2016-02-22 | 2016-02-23 | 567 | — | $0 | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2016-02-22 | 2016-02-23 | 567 | — | $0 | 6,407 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2016-02-21 | 2016-02-23 | 760 | — | $0 | 760 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2016-02-21 | 2016-02-23 | 760 | — | $0 | 5,840 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2016-02-18 | 2016-02-22 | 930 | — | $0 | 1,860 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2016-02-18 | 2016-02-22 | 930 | — | $0 | 5,080 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2015-04-09 | 2015-04-13 | 921 | — | $0 | 921 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2015-02-25 | 2015-02-27 | 1,841 | — | $0 | 1,841 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2015-02-22 | 2015-02-24 | 567 | — | $0 | 567 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2015-02-22 | 2015-02-24 | 567 | — | $0 | 4,150 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2015-02-21 | 2015-02-24 | 760 | — | $0 | 1,520 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2015-02-21 | 2015-02-24 | 760 | — | $0 | 3,583 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2015-02-18 | 2015-02-20 | 930 | — | $0 | 2,790 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2015-02-18 | 2015-02-20 | 930 | — | $0 | 2,823 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2014-02-22 | 2014-02-24 | 567 | — | $0 | 1,134 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2014-02-22 | 2014-02-24 | 567 | — | $0 | 1,893 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2014-02-21 | 2014-02-24 | 759 | — | $0 | 2,280 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2014-02-21 | 2014-02-24 | 759 | — | $0 | 1,326 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2014-02-18 | 2014-02-19 | 3,720 | — | $0 | 3,720 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2013-02-22 | 2013-02-25 | 567 | — | $0 | 1,701 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2013-02-22 | 2013-02-25 | 567 | — | $0 | 567 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2013-02-21 | 2013-02-25 | 3,039 | — | $0 | 3,039 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2012-02-22 | 2012-02-24 | 2,268 | — | $0 | 2,268 | SEC↗ |